WallStSmart

The Clorox Company (CLX)vsUnilever PLC ADR (UL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Unilever PLC ADR generates 653% more annual revenue ($50.62B vs $6.72B). UL leads profitability with a 18.3% profit margin vs 8.7%. CLX appears more attractively valued with a PEG of 1.17. CLX earns a higher WallStSmart Score of 53/100 (C-).

CLX

Buy

53

out of 100

Grade: C-

Growth: 2.0Profit: 7.5Value: 4.7Quality: 3.3
Piotroski: 2/9

UL

Hold

48

out of 100

Grade: D+

Growth: 2.7Profit: 8.5Value: 4.3Quality: 5.0
Piotroski: 4/9Altman Z: 2.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CLXSignificantly Overvalued (-24.4%)

Margin of Safety

-24.4%

Fair Value

$101.26

Current Price

$87.76

$13.50 premium

UndervaluedFair: $101.26Overvalued

Intrinsic value data unavailable for UL.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CLX1 strengths · Avg: 10.0/10
Return on EquityProfitability
652.2%10/10

Every $100 of equity generates 652 in profit

UL4 strengths · Avg: 8.8/10
Return on EquityProfitability
69.2%10/10

Every $100 of equity generates 69 in profit

Market CapQuality
$138.24B9/10

Large-cap with strong market position

Operating MarginProfitability
20.3%8/10

Strong operational efficiency at 20.3%

Free Cash FlowQuality
$1.76B8/10

Generating 1.8B in free cash flow

Areas to Watch

CLX4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Price/BookValuation
118.6x2/10

Trading at 118.6x book value

Revenue GrowthGrowth
-2.0%2/10

Revenue declined 2.0%

EPS GrowthGrowth
-50.1%2/10

Earnings declined 50.1%

UL4 concerns · Avg: 2.8/10
Revenue GrowthGrowth
0.5%4/10

0.5% revenue growth

Debt/EquityHealth
1.983/10

Elevated debt levels

PEG RatioValuation
11.042/10

Expensive relative to growth rate

EPS GrowthGrowth
-5.6%2/10

Earnings declined 5.6%

Comparative Analysis Report

WallStSmart Research

Bull Case : CLX

The strongest argument for CLX centers on Return on Equity. PEG of 1.17 suggests the stock is reasonably priced for its growth.

Bull Case : UL

The strongest argument for UL centers on Return on Equity, Market Cap, Operating Margin. Profitability is solid with margins at 18.3% and operating margin at 20.3%.

Bear Case : CLX

The primary concerns for CLX are Piotroski F-Score, Price/Book, Revenue Growth. Debt-to-equity of 61.33 is elevated, increasing financial risk.

Bear Case : UL

The primary concerns for UL are Revenue Growth, Debt/Equity, PEG Ratio. Debt-to-equity of 1.98 is elevated, increasing financial risk.

Key Dynamics to Monitor

CLX carries more volatility with a beta of 0.54 — expect wider price swings.

UL is growing revenue faster at 0.5% — sustainability is the question.

UL generates stronger free cash flow (1.8B), providing more financial flexibility.

Monitor HOUSEHOLD & PERSONAL PRODUCTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CLX scores higher overall (53/100 vs 48/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

The Clorox Company

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

The Clorox Company, based in Oakland, California, is an American global manufacturer and marketer of consumer and professional products.

Unilever PLC ADR

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Unilever PLC is a fast moving consumer goods company in Asia, Africa, the Middle East, Turkey, Russia, Ukraine, Belarus, America and Europe. The company is headquartered in London, the United Kingdom.

Want to dig deeper into these stocks?